
Orano Med is at the forefront of research in nuclear medicine and is developing new therapies against cancer. Based on its unique expertise in the production of lead-212 (Pb-212) and radiolabeling technologies, Orano Med is developing innovative radioligand therapies which consist of selectively destroying cancer cells while limiting the impact on surrounding healthy cells.
With a solid portfolio of molecules in development capable of targeting various forms of cancer, and a reliable supply chain for Pb-212, Orano Med aims to become a leader in targeted alpha therapies, in particular for patients with currently unmet medical needs.
Orano Med seeks to develop a new generation of targeted therapies against cancer using the unique properties of lead-212 (212Pb), a rare alpha-emitting radioisotope and one of the most potent therapeutic payloads against cancer cells. Orano Med is a biotech company located in France and in the US (Plano, TX, and Brownsburg, IN). With several treatments currently at the clinical stage, Orano Med is a fast-growing R&D and industrial company.
Orano Med LLC is currently looking for a Chief Accountant to manage and develop the Finance activities and support the growth of the US-based companies. This position reports directly to the CFO of Orano Med SAS located in France.
Job Responsibilities:
All candidates must meet the following minimum requirements in order to be considered for this opportunity. Candidates who exceed minimum qualifications may be considered for a higher level position.
Education and Experience:
Preferred: